Cargando…

Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model

Background: Hodgkin's lymphoma (HL) is a unique cancer of lymphocytes that has unknown reason. As lymphocytes are found throughout the lymphatic system, HL can start almost anywhere in the body. It usually starts in a group of lymph nodes in one part of the body; it usually spreads in a predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Javanmardi, Fatemeh, Saki-Malehi, Amal, Ahmadzadeh, Ahmad, Rahim, Fakher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018242/
https://www.ncbi.nlm.nih.gov/pubmed/29951179
_version_ 1783334913984954368
author Javanmardi, Fatemeh
Saki-Malehi, Amal
Ahmadzadeh, Ahmad
Rahim, Fakher
author_facet Javanmardi, Fatemeh
Saki-Malehi, Amal
Ahmadzadeh, Ahmad
Rahim, Fakher
author_sort Javanmardi, Fatemeh
collection PubMed
description Background: Hodgkin's lymphoma (HL) is a unique cancer of lymphocytes that has unknown reason. As lymphocytes are found throughout the lymphatic system, HL can start almost anywhere in the body. It usually starts in a group of lymph nodes in one part of the body; it usually spreads in a predictable form, from one group of lymph nodes to the next. Eventually, it can spread to almost any tissue or organ in the body through the lymphatic system or the bloodstream. So it's important to evaluate the prognostic factors of mortality and recurrence. The aim of this study is to use multistate model to consider the event history of patients and assess important prognostic factors. Materials and Methods: We performed a retrospective review on 389 patients with Hodgkin's disease referred to the Oncology and Hematology Center, Shafa Hospital, Ahvaz during 2002 and 2012. An illness – death model was fitted to assess the hazard of transitions during the course of the disease for each prognostic factor. Results: The results showed that the prevalence rate was higher in male population ≥50 years of age with a hemoglobin level of less than 10.5 g per deciliter and diagnosis of advanced stage of disease. The risk of death for males was twice more than females (HR=2.07). Moreover, patients with mediastina and spleen involvement were more than others in danger of death (1.66 and 1.36, respectively). Conclusion: In conclusion, the multistate model offers an appropriate method to consider the event history of patients and determine main prognostic factors, which play an important role in rapid diagnosis and choosing the best treatment choice for each patient.
format Online
Article
Text
id pubmed-6018242
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
record_format MEDLINE/PubMed
spelling pubmed-60182422018-06-27 Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model Javanmardi, Fatemeh Saki-Malehi, Amal Ahmadzadeh, Ahmad Rahim, Fakher Int J Hematol Oncol Stem Cell Res Original Article Background: Hodgkin's lymphoma (HL) is a unique cancer of lymphocytes that has unknown reason. As lymphocytes are found throughout the lymphatic system, HL can start almost anywhere in the body. It usually starts in a group of lymph nodes in one part of the body; it usually spreads in a predictable form, from one group of lymph nodes to the next. Eventually, it can spread to almost any tissue or organ in the body through the lymphatic system or the bloodstream. So it's important to evaluate the prognostic factors of mortality and recurrence. The aim of this study is to use multistate model to consider the event history of patients and assess important prognostic factors. Materials and Methods: We performed a retrospective review on 389 patients with Hodgkin's disease referred to the Oncology and Hematology Center, Shafa Hospital, Ahvaz during 2002 and 2012. An illness – death model was fitted to assess the hazard of transitions during the course of the disease for each prognostic factor. Results: The results showed that the prevalence rate was higher in male population ≥50 years of age with a hemoglobin level of less than 10.5 g per deciliter and diagnosis of advanced stage of disease. The risk of death for males was twice more than females (HR=2.07). Moreover, patients with mediastina and spleen involvement were more than others in danger of death (1.66 and 1.36, respectively). Conclusion: In conclusion, the multistate model offers an appropriate method to consider the event history of patients and determine main prognostic factors, which play an important role in rapid diagnosis and choosing the best treatment choice for each patient. Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018-01-01 /pmc/articles/PMC6018242/ /pubmed/29951179 Text en Copyright : © International Journal of Hematology-Oncology and Stem Cell Research & Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Javanmardi, Fatemeh
Saki-Malehi, Amal
Ahmadzadeh, Ahmad
Rahim, Fakher
Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
title Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
title_full Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
title_fullStr Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
title_full_unstemmed Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
title_short Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
title_sort assessing prognostic factors in hodgkin's lymphoma: multistate illness-death model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018242/
https://www.ncbi.nlm.nih.gov/pubmed/29951179
work_keys_str_mv AT javanmardifatemeh assessingprognosticfactorsinhodgkinslymphomamultistateillnessdeathmodel
AT sakimalehiamal assessingprognosticfactorsinhodgkinslymphomamultistateillnessdeathmodel
AT ahmadzadehahmad assessingprognosticfactorsinhodgkinslymphomamultistateillnessdeathmodel
AT rahimfakher assessingprognosticfactorsinhodgkinslymphomamultistateillnessdeathmodel